IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regulus Therapeutics Inc (RGLS)

CUSIP: 75915K309 | NYSE | 122 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

IFP Advisors, Inc0
0.0% of portfolio›$760
StyleTurnoverLocationFiled
IFP Advisors, Inc
0$7600.0%GrowthLowTampa, FL2025-07-24